全文获取类型
收费全文 | 8289篇 |
免费 | 763篇 |
国内免费 | 416篇 |
专业分类
耳鼻咽喉 | 82篇 |
儿科学 | 99篇 |
妇产科学 | 111篇 |
基础医学 | 956篇 |
口腔科学 | 207篇 |
临床医学 | 999篇 |
内科学 | 1438篇 |
皮肤病学 | 270篇 |
神经病学 | 529篇 |
特种医学 | 242篇 |
外国民族医学 | 3篇 |
外科学 | 938篇 |
综合类 | 1021篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 539篇 |
眼科学 | 179篇 |
药学 | 856篇 |
4篇 | |
中国医学 | 342篇 |
肿瘤学 | 651篇 |
出版年
2024年 | 16篇 |
2023年 | 110篇 |
2022年 | 259篇 |
2021年 | 358篇 |
2020年 | 245篇 |
2019年 | 276篇 |
2018年 | 313篇 |
2017年 | 264篇 |
2016年 | 263篇 |
2015年 | 358篇 |
2014年 | 403篇 |
2013年 | 449篇 |
2012年 | 557篇 |
2011年 | 621篇 |
2010年 | 376篇 |
2009年 | 277篇 |
2008年 | 440篇 |
2007年 | 463篇 |
2006年 | 493篇 |
2005年 | 436篇 |
2004年 | 282篇 |
2003年 | 297篇 |
2002年 | 212篇 |
2001年 | 177篇 |
2000年 | 176篇 |
1999年 | 194篇 |
1998年 | 134篇 |
1997年 | 117篇 |
1996年 | 88篇 |
1995年 | 80篇 |
1994年 | 66篇 |
1993年 | 37篇 |
1992年 | 99篇 |
1991年 | 58篇 |
1990年 | 69篇 |
1989年 | 34篇 |
1988年 | 53篇 |
1987年 | 49篇 |
1986年 | 39篇 |
1985年 | 35篇 |
1984年 | 20篇 |
1983年 | 17篇 |
1982年 | 13篇 |
1981年 | 20篇 |
1980年 | 11篇 |
1979年 | 21篇 |
1976年 | 15篇 |
1973年 | 9篇 |
1969年 | 7篇 |
1965年 | 6篇 |
排序方式: 共有9468条查询结果,搜索用时 0 毫秒
11.
图娅 《北京中医药大学学报》1997,(5)
21世纪中医学的发展,面临着理顺民族性表述方式与国际性科学内涵关系的问题,因此必须辩证地把握结构与机能、实证科学手段与人文精神、过程与结果之间的谐调统一,这样既符合中医学术体系特征,又能与当代生命科学研究保持一致。 相似文献
12.
Alex Y. Chang Z. Nora Tu Julia L. Smith Philip Bonomi Thomas J. Smith Peter H. Wiernik Ronald Blum 《Investigational new drugs》1995,13(2):137-141
Summary Fifty-five patients with metastatic non-small cell lung cancer (NSCLC) were entered into this phase II randomized study for evaluating three new agents: gallium nitrate, amonafide and teniposide. The patients had to have ECOG performance status 0 or 1, no prior chemotherapy, and adequate hematological, hepatic and renal functions. Forty-seven patients were eligible and evaluable. Fourteen were randomized to receive gallium nitrate, 18 to amonafide and 15 to teniposide. Seventy-four percent of eligible patients were male. The majority of patients (89%) had an ECOG performance status 1. ECOG grade 4 toxicity occurred twice in patients on gallium nitrate, seven times on amonafide and 18 times on teniposide. The cause of death was attributed to amonafide in one patient (from sepsis) and to teniposide in two patients (due to infection and leukopenia). There was no objective response in all the patients entered. The overall survival times ranged from 2 weeks to 156 weeks with a median of 23 weeks. There were no survival differences among the three treatment arms. We conclude that gallium nitrate, amonafide and teniposide are inactive in metastatic NSCLC and do not warrant any further testing in this disease.The contents of this study is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute. 相似文献
13.
应用肝素雾化治疗小儿哮喘性疾病(包括以喘为主的支气管肺炎)16例,其咳喘症状消失和肺部体征消失时间校对照组快,总显效率高。文中还就7例肝素雾化治疗前后血气结果对照,进一步阐述肝素雾化有利于改善通气功能,促进二氧化碳排出和炎症吸收,从而解除支气管痉挛的机理。具有疗效显著,安全可靠,无任何副作用的特点,值得临床推广应用。 相似文献
14.
Monoclonal antibody PAb3 to c-erbB-2/neu protein was utilized in the immunoperoxidase staining of 86 human specimens from oral mucosa. These tissue specimens represented a spectrum from 7 normal to 9 simple hyperplasia, 15 mild dysplasia, 14 moderate dysplasia, 20 severe dysplasia and 21 squamous cell carcinoma. Our study indicated that as the cells acquire a more malignant phenotype, there was a progressive increase in neu expression. It also suggested that neu may be involved in the development of oral cancers and that its evaluation in the early stages may assist in the diagnosis and management of oral cancers. 相似文献
15.
Increased expression of certain glutathione S-transferase (GST) isoenzymes has frequently been associated with the development of resistance to alkylating agents and other classes of antineoplastic drugs in drug-selected cell lines. The question arises whether this phenomenon is causal or is a stress-induced response associated with drug resistance in these cell lines. We have constructed mammalian expression vectors containing the human GST mu and GST alpha 2 (Ha2) cDNAs and stably transfected them into the human breast cancer cell line MCF-7. Whereas the parental and pSV2neo-transfected cell lines display low GST activity, three individual transfected clones were identified in each group that expressed either GST mu or GST alpha 2. The range of GST activities was similar to those observed in cells selected for anticancer drug resistance. The GST mu specific activities were 56, 150, and 340 mlU/mg, compared with 10 mlU/mg of endogenous GST mu in control lines. Specific activities in GST alpha 2-transfected clones were 17, 28, and 52 mlU/mg, compared with no detectable alpha class GST in control lines. These clonal lines and the parental and pSV2neo-transfected control lines were tested for sensitivity to antineoplastic agents and other cytotoxic compounds. The clones with the highest activity in each group were 1.7-fold (GST alpha 2) to 2.1-fold (GST mu) resistant to the toxic effects of ethacrynic acid, a known substrate for GSTs. However, the GST-transfected cell lines were not resistant to doxorubicin, L-phenylalanine mustard, bis(2-chloroethyl)-1-nitrosourea, cisplatin, chlorambucil, or the GST substrates 1-chloro-2,4-dinitrobenzene or tert-butyl hydroperoxide. Thus, although L-phenylalanine mustard, bis(2-chloroethyl)-1-nitrosourea, chlorambucil, tert-butyl hydroperoxide, and 1-chloro-2,4-dinitrobenzene are known to be metabolized by glutathione-dependent GST-catalyzed reactions, there was no protection against any of these agents in MCF-7 cell lines overexpressing GST mu or GST alpha 2. We conclude that, at the levels of GST obtained in this transfection model system, overexpression of GST mu or GST alpha 2 is not by itself sufficient to confer resistance to these anticancer agents. These studies do not exclude the possibility that GST may be a marker of drug resistance or that other gene products not expressed in MCF-7 cells might cooperate with GST to confer drug resistance. 相似文献
16.
Age and gender related changes in stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil. 总被引:2,自引:2,他引:0 下载免费PDF全文
S K Gupta L Atkinson T Tu J A Longstreth 《British journal of clinical pharmacology》1995,40(4):325-331
1. Pharmacokinetics and pharmacodynamics of R- and S-verapamil and R- and S-norverapamil were studied at steady state following administration of 180 mg verapamil delivered by a controlled-release gastrointestinal therapeutic system (COER-verapamil). 2. Of the 30 young (19 to 43 years) and 30 elderly subjects (65 to 80 years) enrolled, approximately half of each age group were women; all subjects were healthy and none were smokers. 3. Mean R- and S-verapamil and R- and S-norverapamil Cmax, Cmin, and AUC values for elderly subjects were 1.2 to 2.2 times greater than those for young subjects; these differences were statistically significant at P < 0.05. Median tmax values for young and elderly subjects were not significantly different for any enantiomer. The mean half-life values of R- and S-verapamil for elderly subjects were approximately 20 h compared with approximately 13 h for young subjects, respectively. The mean half-life values of R- and S-norverapamil for elderly subjects were approximately 31 h and 20 h, respectively, compared with approximately 19 h and 21 h for young subjects, respectively. 4. In both age groups, the mean plasma verapamil concentrations of each enantiomer were higher for women than for men at all time points. 5. Mean arterial pressure (MAP) had a significant correlation to R- (r2 = 0.86) and S-verapamil (r2 = 0.87) concentration values that was not influenced by either gender or age of the patient. Change in PR-interval also had a significant correlation to R- and S-verapamil concentration values. However, the sensitivity of the response to changes in R- and S-verapamil concentration values in elderly subjects was about 1/5 of that in younger subjects. 相似文献
17.
18.
John Goffin Stefan Baral Dongsheng Tu Dora Nomikos Lesley Seymour 《Clinical cancer research》2005,11(16):5928-5934
PURPOSE: Tumor responses in early-phase trials are used to determine whether new agents warrant further study. Given that spontaneous regressions are observed in melanoma and renal cell carcinoma, this study assessed whether tumor responses, particularly in these two tumor types, predict for future regulatory drug approval. EXPERIMENTAL DESIGN: The literature was reviewed to assess tumor response rates to cytotoxic agents in phase I and II trials in the following solid tumors: melanoma, renal cell carcinoma, non-small-cell lung cancer, breast cancer, ovarian cancer, colorectal cancer, and other solid tumors. Response rates were categorized and the relationship of these categories to the end point of regulatory drug approval was determined. RESULTS: Fifty-eight drugs were assessed in 100 phase I trials, and 46 of these drugs were also studied in 499 phase II trials. Higher overall response rates in both phase I trials (P = 0.03) and phase II trials (P < 0.0001) were predictive of regulatory approval. However, response in melanoma or renal cell carcinoma was not predictive for either phase I or phase II studies. CONCLUSIONS: For cytotoxic agents, although overall objective response rates reliably predict subsequent marketing approval, isolated responses in melanoma and renal cell carcinoma are not predictive. 相似文献
19.
20.
笔者通过对35例阻塞怀黄疸的CT所见,指出了胆道扩张征象可作为鉴别肝内、阻阻塞性黄疸的可靠指标,再结合临床及CT的初期征象,可更加提高其鉴别诊断准确率。本文对这些指标的可靠性进行重点讨论。提出了该特点是特别胆道管囊肿的重要指征,即后者的胆道扩张为局部性或节段性。本文对良、恶性病变所致的胆道扩张形态亦进行了对照分析,发现二阻之间无明显性差异。 相似文献